The total investment in malaria research in the database was £352.9 million, 13.6% of the overall infectious disease research portfolio.

Within malaria, investments relating to therapeutics totalled £104.1 million (29.5%), drug resistance £21.3 million (6.0%), vaccine research £20.7 million (6.0%), and paediatrics £10.2 million (2.9%).

 

Tweet about this on TwitterShare on Google+Share on LinkedInShare on Facebook